Cello Health logo

CLL - Cello Health Share Price

121.16p -1.8  -1.5%

Last Trade - 3:42pm

Sector
Consumer Cyclicals
Size
Small Cap
Market Cap £130.5m
Enterprise Value £124.1m
Revenue £165.6m
Position in Universe 915th / 1830
Bullish
Bearish
Unlock CLL Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CLL Revenue Unlock CLL Revenue

Net Income

CLL Net Income Unlock CLL Revenue

Normalised EPS

CLL Normalised EPS Unlock CLL Revenue

PE Ratio Range

CLL PE Ratio Range Unlock CLL Revenue

Dividend Yield Range

CLL Dividend Yield Range Unlock CLL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CLL EPS Forecasts Unlock CLL Revenue
Profile Summary

Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.

Directors
Last Annual December 31st, 2018
Last Interim December 31st, 2018
Incorporated May 5, 2004
Public Since November 9, 2004
No. of Shareholders: n/a
No. of Employees: 973
Sector Consumer Cyclicals
Industry Media & Publishing
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 106,088,917
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CLL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CLL
Upcoming Events for CLL
Similar to CLL
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.